Off‐label use of tocilizumab in patients with SARS‐CoV‐2 infection-Reference-Cited by-同舟云学术

Off‐label use of tocilizumab in patients with SARS‐CoV‐2 infection

Published:2020-06-29 Issue:10 Volume:92 Page:1787-1788
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Di Giambenedetto Simona¹²,Ciccullo Arturo¹,Borghetti Alberto¹^ORCID,Gambassi Giovanni³⁴,Landi Francesco³⁵,Visconti Elena¹,Zileri Dal Verme Lorenzo⁶,Bernabei Roberto³⁵,Tamburrini Enrica¹²,Cauda Roberto¹²,Gasbarrini Antonio⁶

Affiliation:

1. UOC Malattie Infettive Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma Italy

2. Dipartimento di Sicurezza e Bioetica Sezione Malattie Infettive Università Cattolica del Sacro Cuore Roma Italy

3. Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy

4. Institute of Internal Medicine, Agostino Gemelli Hospital Catholic University of the Sacred Heart Rome Italy

5. Institute of Internal Medicine and Geriatrics Università Cattolica del Sacro Cuore Rome Italy

6. Dipartimento Scienze Mediche e Chirurgiche Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore Rome Italy

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25897

Reference9 articles.

1. PanL YiL LinQ et al.Tocilizumab treatment in COVID‐19: a single center experience.J Med Virol.2020;92(7):814‐818.

2. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

3. Understanding of COVID‐19 based on current evidence

4. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

5. Gilead.Gilead Sciences Statement on the Company's Ongoing Response to the 2019 Novel Coronavirus (2019‐nCoV).https://www.gilead.com/news-and-press/company-statements/gilead-sciences-statement-on-the-company-ongoing-response-to-the-2019-new-coronavirus

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of tocilizumab administration on inflammatory markers in COVID-19 patients;The Egyptian Journal of Bronchology;2024-08-17

2. The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic;Medicine, Health Care and Philosophy;2023-12-28

3. Immunosenescence and Inflammaging in COVID-19;Viral Immunology;2023-11-01

4. Hemophagocytic Syndrome and COVID-19: A Comprehensive Review;Cureus;2023-03-14

5. A Review of Potential Therapeutic Strategies for COVID-19;Viruses;2022-10-25